AzTrials
AzTrials

C5 PalsyC-FIVENCT05247450

Conventional-therapy & FES-therapy In-Veritas Effects Study

A study testing Functional electrical stimulation therapy (FES-t) and Conventional physiotherapy in people with C5 Palsy, run by University Health Network, Toronto at 1 site in Canada.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This randomized clinical trial will primarily compare the effectiveness of conventional physiotherapy alone with combined conventional physiotherapy and FES-t along with task-specific training in terms of the improvement of the functional and neurological recovery of patients with persistent C5 palsy. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
C5 Palsy
What is being tested?
Functional electrical stimulation therapy (FES-t) and Conventional physiotherapy
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16 participants
Where
1 siteCanada
Study dates
16 Aug 2023to 31 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • New unilateral or bilateral, persistent C5 palsy (for at least 3 months) after surgical treatment for degenerative cervical myelopathy

Who cannot join

  • Contraindication for FES-t
  • Contraindication for neurophysiological testing
  • Contraindication for MRI scanning
  • Uncontrolled cardiovascular conditions
  • Other medical conditions that can limit treatment protocols
  • Other neurological diseases
Show all 12Show fewer
  • Significant persisting mental illness
  • Diagnosed learning disabilities
  • Substance abuse over 6 months prior to recruitment
  • Hearing and visual deficits sufficient to affect test performance
  • Reduced passive range of motion (ROM) of the shoulder ("frozen shoulder")
  • Inability to participate in and intensive outpatient rehabilitation program

Trial locations and contacts

1 site in 1 country.

Canada1 site, 1 recruiting
  • KITE Toronto Research Institute

    Toronto, Ontario, M4G 3V9

    Mitsue Aibe, 4165973422 ext. 6285, Mitsue.Aibe@uhn.ca

    Recruiting

Other trials in Canada

About this study

Official title: Conventional-therapy & FES-therapy In-Veritas Effects Study (C-FIVE Study): Rehabilitation of the Upper Extremity for New Persistent C5 Palsy After Surgical Treatment of Patients With Degenerative Cervical Myelopathy

This randomized clinical trial will primarily compare the effectiveness of conventional physiotherapy alone with combined conventional physiotherapy and FES-t along with task-specific training in terms of the improvement of the functional and neurological recovery of patients with persistent C5 palsy.

Read the detailed description

This randomized clinical trial will primarily compare the effectiveness of conventionalphysiotherapy alone with combined conventional physiotherapy and FES-t along with task-specific training in terms of the improvement of the functional and neurological recovery of patients with persistent C5 palsy. Secondarily, this clinical trial will evaluate the effectiveness of combined conventional physiotherapy and FES-t along with task-specific training outcome compared to conventional physiotherapy alone with regards to improved connectivity andexcitability in the ascending and descending pathways as assessed using neurophysiological tests and functional MRI analysis.

Conditions
C5 Palsy
Being tested
Functional electrical stimulation therapy (FES-t), Conventional physiotherapy
Keywords
Functional electrical stimulation therapy, Degenerative Cervical Myelopathy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Functional electrical stimulation therapy (FES-t)Device

    Functional electrical stimulation therapy (FES-t) that will use a multichannel device (MyndSearch device).

  • Conventional physiotherapyOther

    Also called Standard of Care

    Conventional physiotherapy is the current standard of care for rehabilitation of C5 palsy

Study groups in NCT05247450
Study groupRoleWhat they receive
FES-t along with conventional physiotherapyExperimentalCombined conventional physiotherapy and functional electrical stimulation therapy (FES-t) along with task-specific training
Receives: Device: Functional electrical stimulation therapy (FES-t); Other: Conventional physiotherapy
Conventional physiotherapy aloneActive comparatorConventional physiotherapy alone (current standard of care)
Receives: Other: Conventional physiotherapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Spinal Cord Independence Measure (SCIM) score

    The SCIM is a clinician-administered disability scale developed to specifically address the ability of SCI patients to perform basic activities of daily living independently (SCIM varies from 0 (completely dependent) to 100 (completely independent).

    Measured: up to 10 weeks post-intervention

Secondary outcomes (4)
  1. Change in Manual muscle testing

    Clinical assessment of the muscle power that varies from 0 (complete paralysis) to 5 (normal)

    Measured: up to 10 weeks post-intervention

  2. change in Modified Japanese Outcome Association (mJOA) Score

    Clinical assessment of the upper and lower extremities, and bladder function (mJOA varies from 0 [most impaired and disabled] to 18 [normal function]).

    Measured: up to 10 weeks post-intervention

  3. Change in neurophysiological parameters

    Neurophysiological parameters of neuroplasticity

    Measured: up to 10 weeks post-intervention

  4. Change in Functional Magnetic Resonance Imaging (MRI)

    Functional MRI analyses will be focused on improvement of the functional connectivity within the somatosensory and motor cortices and pathways in the brain.

    Measured: 6 to10 weeks post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Feb 2022
  2. Study start16 Aug 2023
  3. Primary completion30 Aug 2025 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
16 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05247450
Sponsor's protocol ID
21-5580
Acronym
C-FIVE
Status last verified
Jan 2024
First submitted
29 Oct 2021
Last updated
11 Jan 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Functional electrical stimulation therapy (FES-t) and Conventional physiotherapy in people with C5 Palsy, run by University Health Network, Toronto at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mitsue Aibe, MD (4165973422 ext. 6285, Mitsue.Aibe@uhn.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Spinal Cord Independence Measure (SCIM) score (time frame: up to 10 weeks post-intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in